Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

  • STATUS
    Recruiting
  • participants needed
    140
  • sponsor
    Universiti Kebangsaan Malaysia Medical Centre
Send
Updated on 5 August 2020
See if I qualify

Summary

This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.

Description

This is a double blinded study whereby both the surgeons and patients are blinded from the sedative agent used. Patients admitted to UKMMC requiring ERCP will randomized into 2 groups after evaluating the inclusion and exclusion criteria. Patients will be divided into two arms, Midazolam and Ketamine group respectively. Before the initiation of the the scope, patient would be given specified dose of sedation accordingly. All the parameters and outcome would be measured during and after the procedure.

Details
Condition Ketamine Adverse Reaction
Age 16years - 100years
Treatment Ketamine Hydrochloride
Clinical Study IdentifierNCT04490031
SponsorUniversiti Kebangsaan Malaysia Medical Centre
Last Modified on5 August 2020

Eligibility

 Yes No Not Sure

Inclusion Criteria

Malaysian citizens of who is able to give valid consent
Patient planned for ERCP (either emergency or elective)

Exclusion Criteria

Known hypersensitivity towards Ketamine or Midazolam
Patient refusal to participate or unable to give consent
Increased intracranial pressure, acute stroke (<3 months), intracranial haemorrhage (<3 months)
Uncontrolled hypertension (BP>160/100) and tachycardia (Heart rate >120)
Acute myocardial infarction, acute coronary syndrome (<3 months)
Tachyarrythmia
Pregnancy
IVDU or substance abuse patient
Patient with history of hallucination
Child's Pugh Class C
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.